Answers are grounded in this paper and cite their sources.
End-stage renal disease is associated with the inflammatory statecharacterized by infiltrating macrophages/lymphocytes, a majorsource of chemokines. The aim of this study was to determine theassociation of CCR2 G190A polymorphism in patients with chronicrenal failure (CRF) requiring hemodialysis. Seventy CRF patients andthirty healthy controls were enrolled in the current study; PCR-RFLPtechnique was used to assess the gene frequencies of CCR2 G190A.The results of the present study showed that there was a significantdifference in the genotype and allele frequency distribution of CCR2G190A in CRF patients and control subjects. A significant associationwas found between CCR2 G190A and CRF risk, especially, the AAgenotype (OR= 2.5, 95% CI=0.26-23.66) and A allele (OR=2.9, 95%CI=1.14-7.3). The polymorphism was significantly associated with thepresence of diabetes mellitus. From this study, it could be concludedthat, a significant association was found between the AA genotype ofCCR2 G190A polymorphism and CRF. Other chemokinepolymorphisms in renal pathologies have to be further investigatedwith larger population based studies.
No takes yet. Share an insight, caveat, or question.
Elhelbawy et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: